Javascript was detected to be disabled. Javascript is required for some functions on this website.

The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyse health economic and treatment strategies (see Profile). Learn more about the institute's Purpose and Projects.

News

Swiss Day of Laboratory Medicine - “Keynote” on the Value of Laboratory Medicine in Switzerland

Michael Schlander will discuss the ´Value of Laboratory Medicine in Switzerland´ at the Swiss Day of Laboratory Medicine [Tag der Labormedizin] in Berne, Switzerland, on Friday, November 03, 2023.

His presentation will outline key economic data on Swiss laboratory medicine and address the methodology used to assess the value of laboratory medicine in Switzerland. Key points will include evaluating new technology during the life cycle, using illustrative examples. Future perspectives to be highlighted are the potential of precision medicine, and the role of laboratory medicine in pre- and post-analytics. The presentation will be followed by a panel discussion with Swiss experts.

Read more …

Presentation on "Changing Perspectives on Value in HTA"

Michael Schlander presented "Changing Perspectives on Value" in Health Technology Assessment (HTA) and discussed with Daniel Ollendorf, Magdalena Wladysiuk and Tomasz Jan Prycel “The Road Ahead for HTA” at the 18th International Evidence-Based Health Care (EBHC) Symposium in Krakow, Poland, on Monday, October 09, 2023.

Read more …

Open Access Book "Nutzen der Labormedizin in der Schweiz"

"Nutzen der Labormedizin in der Schweiz" ["Value of Laboratory Medicine in Switzerland"]
--- Open Access Book published with Springer Nature ---

Die Labormedizin gilt nach Expertenmeinung als ausschlaggebend für rund 70 % aller klinischen Entscheide, wird jedoch hinsichtlich ihrer Kosten und des Kosten-Nutzen-Verhältnisses labordiagnostischer Verfahren kritisch betrachtet. Mit diesem Open-Access-Buch veröffentlicht das Institut für Innovation & Evaluation im Gesundheitswesen eine von der schweizerischen Foederatio Analyticorum Medicinalium Helveticorum (FAMH) veranlassten Studie, um den gegenwärtig generierten und zukünftig zu erwartenden Nutzen von Laboranalysen aus der Perspektive von Patientinnen/Patienten und der Gesellschaft zu untersuchen.

Read more …

The Role of Budget Impact in Health Technology Assessments (HTAs)

Recently published article on "The HTA-informed Decision-Making by GBA/IQWiG in Germany and NICE in England: The Role of Budget Impact" in Value in Health (online available as of March 2023).

Read more …

Recently published Research Articles

Recently published research articles in Frontiers Public Health (Open Access; available as of January 2023), in MDM Policy & Practice (Open Access; online available as of January 2023) and in Oncology Research (Open Access; online available as of February 2023) are available.

Read more …